diazoxide has been researched along with Drug Refractory Epilepsy in 1 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
De Los Santos-La Torre, MA | 2 |
Del Águila-Villar, CM | 2 |
Lu-de Lama, LR | 2 |
Nuñez-Almache, O | 2 |
Chávez-Tejada, EM | 2 |
Espinoza-Robles, OA | 2 |
Pinto-Ibárcena, PM | 2 |
Calagua-Quispe, MR | 2 |
Azabache-Tafur, PM | 2 |
Tucto-Manchego, RM | 2 |
1 other study available for diazoxide and Drug Refractory Epilepsy
Article | Year |
---|---|
Hyperinsulinism-hyperammonemia syndrome in two Peruvian children with refractory epilepsy.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Drug Resistant Epilepsy; Epilepsy; Glutamate Dehydroge | 2023 |
Hyperinsulinism-hyperammonemia syndrome in two Peruvian children with refractory epilepsy.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Drug Resistant Epilepsy; Epilepsy; Glutamate Dehydroge | 2023 |
Hyperinsulinism-hyperammonemia syndrome in two Peruvian children with refractory epilepsy.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Drug Resistant Epilepsy; Epilepsy; Glutamate Dehydroge | 2023 |
Hyperinsulinism-hyperammonemia syndrome in two Peruvian children with refractory epilepsy.
Topics: Child; Congenital Hyperinsulinism; Diazoxide; Drug Resistant Epilepsy; Epilepsy; Glutamate Dehydroge | 2023 |